Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $153,323 (100.0% shares, 0.0% debt)

Holdings (14)

REPL Replimune Group 35.1%

Value ($000) $53,866 Shares 3,050,187 Est. Cost $17.40 Unrealized +36.7%

NUVB Nuvation Bio 16.3%

Value ($000) $25,020 Shares 15,072,340 Est. Cost $11.18 Unrealized -81.9%

— Morphic Holding 14.7%

Value ($000) $22,498 Shares 597,723 Est. Cost $19.82 Unrealized —

— Alpine Immune Sciences 10.2%

Value ($000) $15,668 Shares 2,029,580 Est. Cost $9.48 Unrealized —

— Ikena Oncology 5.1%

Value ($000) $7,759 Shares 2,249,123 Est. Cost $28.25 Unrealized —

— Theseus Pharmaceuticals 4.1%

Value ($000) $6,318 Shares 711,479 Est. Cost $12.68 Unrealized —

— Kronos Bio 3.6%

Value ($000) $5,575 Shares 3,818,283 Est. Cost $29.87 Unrealized —

— Paratek Pharmaceuticals 3.3%

Value ($000) $5,007 Shares 1,971,241 Est. Cost $34.18 Unrealized —

— Spruce Biosciences 3.1%

Value ($000) $4,776 Shares 2,161,022 Est. Cost $24.31 Unrealized —

SANA Sana Biotechnology, Inc. 1.8%

Value ($000) $2,759 Shares 843,750 Est. Cost $32.56 Unrealized -87.7%

IMUX Immunic Inc 1.7%

Value ($000) $2,664 Shares 1,788,160 Est. Cost $13.89 Unrealized -86.6%

SYRS Syros Pharmaceuticals 0.4%

Value ($000) $671 Shares 251,270 Est. Cost $8.12 Unrealized -52.3%

— Jounce Therapeutics 0.3%

Value ($000) $510 Shares 275,513 Est. Cost $21.99 Unrealized —

— Senti Biosciences, Inc. 0.2%

Value ($000) $231 Shares 195,792 Est. Cost $1.97 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune Group	3,050,187	$53,866	35.1%	$17.40	+36.7%	Common Stock	76029N106
NUVB	Nuvation Bio	15,072,340	$25,020	16.3%	$11.18	-81.9%	Common Stock Class A	67080N101
—	Morphic Holding	597,723	$22,498	14.7%	$19.82	—	Common Stock	61775R105
—	Alpine Immune Sciences	2,029,580	$15,668	10.2%	$9.48	—	Common Stock	02083G100
—	Ikena Oncology	2,249,123	$7,759	5.1%	$28.25	—	Common Stock	45175G108
—	Theseus Pharmaceuticals	711,479	$6,318	4.1%	$12.68	—	Common Stock	88369M101
—	Kronos Bio	3,818,283	$5,575	3.6%	$29.87	—	Common Stock	50107A104
—	Paratek Pharmaceuticals	1,971,241	$5,007	3.3%	$34.18	—	Common Stock	699374302
—	Spruce Biosciences	2,161,022	$4,776	3.1%	$24.31	—	Common Stock	85209E109
SANA	Sana Biotechnology, Inc.	843,750	$2,759	1.8%	$32.56	-87.7%	Common Stock	799566104
IMUX	Immunic Inc	1,788,160	$2,664	1.7%	$13.89	-86.6%	Common Stock	4525EP101
SYRS	Syros Pharmaceuticals	251,270	$671	0.4%	$8.12	-52.3%	Common Stock	87184Q206
—	Jounce Therapeutics	275,513	$510	0.3%	$21.99	—	Common Stock	481116101
—	Senti Biosciences, Inc.	195,792	$231	0.2%	$1.97	—	Common Stock	81726A100